Peritoneal carcinomatosis: A final frontier

Annals of Surgical Oncology

Volumn 10, Issue 5, 2003, Pages 484-485

  Sticca, Robert P ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER MORTALITY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; EDITORIAL; HUMAN; HYPERTHERMIC THERAPY; MEDICAL DOCUMENTATION; MORBIDITY; PROGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; CARCINOMA; COLORECTAL TUMOR; INFUSION; METASTASIS; MULTIMODALITY CANCER THERAPY; NOTE; PATHOLOGY; PERITONEUM TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0043288098     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.04.907     Document Type: Editorial

References (9)

1. Pilati P, Mocellin S, Rossi C, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003;10:508-13.
2. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies, results of the EVOCAPE 1 Multicenter Prospective Study. Cancer 2000;88:358-63.
3. Sugarbaker P. Peritoneal Carcinomatosis: Drugs and Diseases. Boston: Kluwer, 1996.
4. Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-6.
5. Witkamp AJ, deBree E, Kaag MM, et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001;37:979-84.
6. McQuellon RP, Logie BW, Lehman AB, et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2003;10:155-62.
7. McCarter M, Fong Y. Role for cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 2001;8:38-43.
8. Morton D, Ollila D, Hsueh E, et al. Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma. Ca Cancer J Clin 1999;49:101-16.
9. Zoetmulder F, Verwaal V, Ruth S. Hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin-C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin. Abstract presented at: Proceedings of American Society of Clinical Oncology; May 2002; Orlando, FL.